NeuBase Therapeutics, Inc. (NBSE) has a market capitalization of $1.42M and trades at $0.38. The 52-week range is 0.36-4.44.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-21.08.
The stock has a beta of 0.95, operates in the Healthcare sector.
